SNODGRASS H. RALPH 4
4 · VistaGen Therapeutics, Inc. · Filed Nov 21, 2019
Insider Transaction Report
Form 4
SNODGRASS H. RALPH
DirectorPRES./CHIEF SCIENTIFIC OFFICER
Transactions
- Purchase
Common Stock
2019-11-20$0.34/sh+15,000$5,100→ 15,000 total(indirect: By Trust)
Holdings
- 62,724
Common Stock